A Study in Patients With Asthma
NCT01570478
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Foster® NEXThaler® 100/6 µg/unit dose
DRUG:
Seretide® Accuhaler® 250/50 µg/actuation
Sponsor
Chiesi Farmaceutici S.p.A.